MYRIAD GENETICS, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
MYRIAD GENETICS, INC. (MYGN) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$20.50 million for the 9-month period ending 2018-03-31, per its 10-Q filed 2018-05-09.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-05-09
- MYRIAD GENETICS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2018-03-31 was -$700.00K, a 107.37% decline year-over-year.
- MYRIAD GENETICS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-12-31 was -$4.60M.
- MYRIAD GENETICS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was -$15.20M.
- MYRIAD GENETICS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was $4.30M.
- MYRIAD GENETICS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was -$146.30M.
- MYRIAD GENETICS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$91.40M, a 323.47% decline from fiscal 2015.
- MYRIAD GENETICS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was $40.90M.
- MYRIAD GENETICS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$17.10M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-03-31 | -$700.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-09 | -$5.30M derived: sum of 2 quarters · filed 2018-05-09 | -$20.50M 10-Q · filed 2018-05-09 | -$16.20M derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2017-12-31 | -$4.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-07 | -$19.80M 10-Q · filed 2018-02-07 | -$15.50M derived: sum of 3 quarters · filed 2018-02-07 | -$6.00M derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2017-09-30 | -$15.20M 10-Q · filed 2017-11-08 | -$10.90M derived: sum of 2 quarters · filed 2017-11-08 | -$1.40M derived: sum of 3 quarters · filed 2018-05-09 | -$3.50M derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2017-06-30 | $4.30M derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-09 | $13.80M derived: sum of 2 quarters · filed 2018-05-09 | $11.70M derived: sum of 3 quarters · filed 2018-05-09 | -$146.30M 10-K · filed 2017-08-09 | ||||
| 2017-03-31 | $9.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-09 | $7.40M derived: sum of 2 quarters · filed 2018-05-09 | -$150.60M 10-Q · filed 2018-05-09 | -$194.40M derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2016-12-31 | -$2.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-07 | -$160.10M 10-Q · filed 2018-02-07 | -$203.90M derived: sum of 3 quarters · filed 2018-02-07 | -$220.00M derived: sum of 4 quarters · filed 2018-02-07 | ||||
| 2016-09-30 | -$158.00M 10-Q · filed 2017-11-08 | -$201.80M derived: sum of 2 quarters · filed 2017-11-08 | -$217.90M derived: sum of 3 quarters · filed 2017-11-08 | -$258.40M derived: sum of 4 quarters · filed 2017-11-08 | ||||
| 2016-06-30 | -$43.80M derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-09 | -$59.90M derived: sum of 2 quarters · filed 2017-08-09 | -$100.40M derived: sum of 3 quarters · filed 2017-08-09 | -$91.40M 10-K · filed 2017-08-09 | ||||
| 2016-03-31 | -$16.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-03 | -$56.60M derived: sum of 2 quarters · filed 2017-05-03 | -$47.60M 10-Q · filed 2017-05-03 | -$50.40M derived: sum of 4 quarters · filed 2017-08-09 | ||||
| 2015-12-31 | -$40.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-08 | -$31.50M 10-Q · filed 2017-02-08 | -$34.30M derived: sum of 3 quarters · filed 2017-08-09 | -$9.40M derived: sum of 4 quarters · filed 2017-08-09 | ||||
| 2015-09-30 | $9.00M 10-Q · filed 2016-11-02 | $6.20M derived: sum of 2 quarters · filed 2017-08-09 | $31.10M derived: sum of 3 quarters · filed 2017-08-09 | $22.40M derived: sum of 4 quarters · filed 2017-08-09 | ||||
| 2015-06-30 | -$2.80M derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-09 | $22.10M derived: sum of 2 quarters · filed 2017-08-09 | $13.40M derived: sum of 3 quarters · filed 2017-08-09 | $40.90M 10-K · filed 2017-08-09 | ||||
| 2015-03-31 | $24.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-04 | $16.20M derived: sum of 2 quarters · filed 2016-05-04 | $43.70M 10-Q · filed 2016-05-04 | $43.71M 10-Q · filed 2015-05-06 | $25.37M derived: sum of 4 quarters · filed 2016-08-10 | |||
| 2014-12-31 | -$8.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-03 | $18.80M 10-Q · filed 2016-02-03 | $18.83M 10-Q · filed 2015-02-04 | $470.00K derived: sum of 3 quarters · filed 2016-08-10 | -$573.00K derived: sum of 4 quarters · filed 2016-08-10 | |||
| 2014-09-30 | $27.50M 10-Q · filed 2015-11-04 | $27.58M 10-Q · filed 2014-11-05 | $9.17M derived: sum of 2 quarters · filed 2016-08-10 | $8.13M derived: sum of 3 quarters · filed 2016-08-10 | $18.96M derived: sum of 4 quarters · filed 2016-08-10 | |||
| 2014-06-30 | -$18.33M derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-10 | -$19.37M derived: sum of 2 quarters · filed 2016-08-10 | -$8.54M derived: sum of 3 quarters · filed 2016-08-10 | -$17.10M 10-K · filed 2016-08-10 | -$17.67M 10-K · filed 2014-08-13 | |||
| 2014-03-31 | -$1.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-06 | $9.79M derived: sum of 2 quarters · filed 2015-05-06 | $1.23M 10-Q · filed 2015-05-06 | |||||
| 2013-12-31 | $10.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-04 | $2.27M 10-Q · filed 2015-02-04 | ||||||
| 2013-09-30 | -$8.56M 10-Q · filed 2014-11-05 | |||||||
| 2013-06-30 | -$74.90M 10-K · filed 2015-08-12 | -$75.59M 10-K · filed 2014-08-13 | ||||||
| 2012-06-30 | -$38.89M 10-K · filed 2014-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |